Found: 24
Select item for more details and to access through your institution.
Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 348, doi. 10.1002/ajh.26796
- By:
- Publication type:
- Article
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 309, doi. 10.1002/ajh.26792
- By:
- Publication type:
- Article
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E35, doi. 10.1002/ajh.26789
- By:
- Publication type:
- Article
N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 290, doi. 10.1002/ajh.26805
- By:
- Publication type:
- Article
Fetal hemoglobin per erythrocyte (HbF/F‐cell) after gene therapy for sickle cell anemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E32, doi. 10.1002/ajh.26791
- By:
- Publication type:
- Article
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 338, doi. 10.1002/ajh.26788
- By:
- Publication type:
- Article
The feasibility of additional CD19‐targeted cellular therapy in relapsed/refractory B‐ALL with re‐emergence of CD19 antigen after prior CD19‐negative relapse.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E38, doi. 10.1002/ajh.26787
- By:
- Publication type:
- Article
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
- By:
- Publication type:
- Article
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 264, doi. 10.1002/ajh.26785
- By:
- Publication type:
- Article
Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 300, doi. 10.1002/ajh.26784
- By:
- Publication type:
- Article
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E24, doi. 10.1002/ajh.26779
- By:
- Publication type:
- Article
Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E41, doi. 10.1002/ajh.26782
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent therapy in myelodysplastic syndromes: Big picture perspective.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 225, doi. 10.1002/ajh.26781
- By:
- Publication type:
- Article
SARS‐CoV‐2 mRNA vaccination of aplastic anemia patients is safe and effective.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E20, doi. 10.1002/ajh.26780
- By:
- Publication type:
- Article
Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 361, doi. 10.1002/ajh.26783
- By:
- Publication type:
- Article
Proposed risk‐scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 251, doi. 10.1002/ajh.26774
- By:
- Publication type:
- Article
Predictors of anemia response to momelotinib therapy in myelofibrosis and impact on survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 282, doi. 10.1002/ajh.26778
- By:
- Publication type:
- Article
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 272, doi. 10.1002/ajh.26771
- By:
- Publication type:
- Article
Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 229, doi. 10.1002/ajh.26768
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation for patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 322, doi. 10.1002/ajh.26763
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 223, doi. 10.1002/ajh.26605
- Publication type:
- Article
The elusive but classic presentation of small cell variant of ALK+ anaplastic large cell lymphoma (ALCL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 368, doi. 10.1002/ajh.26394
- By:
- Publication type:
- Article
Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2‐ALK fusion.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 365, doi. 10.1002/ajh.26107
- By:
- Publication type:
- Article
G6PD deficiency in patients identified as female.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 359, doi. 10.1002/ajh.26704
- By:
- Publication type:
- Article